首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1459628

全球宏基因組市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Metagenomics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年03月01日 | 出版商:

Value Market Research | 英文 174 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球宏基因組市場需求預計將從 2023 年的 23.8 億美元達到 2032 年近 76.8 億美元的市場規模，2024-2032 年研究期間CAGR為 13.91%。

宏基因體學是一種研究從水、土壤或人體等環境樣本中回收的遺傳物質的科學方法，無需分離和培養個體生物體。它提供了這些環境中微生物群落的遺傳組成、多樣性和功能潛力的見解，並使研究人員能夠了解微生物在各種生態系統中的作用，包括它們對人類健康、農業和環境過程的影響。

市場動態

定序技術和生物資訊學工具的進步推動了宏基因組市場。宏基因組研究使科學家能夠以前所未有的深度和準確性分析複雜的微生物群落。此外，人們對人類微生物組在健康和疾病中的作用的認知不斷增強，刺激了個人化醫療、益生菌和微生物組療法中對宏基因組解決方案的需求。此外，政府對微生物組科學研究的措施和資金支持透過促進學術、工業和政府機構之間的創新和合作加速了市場的成長。此外，宏基因體學在食品安全、工業生物加工和環境修復中的廣泛應用凸顯了其多功能性和市場潛力。然而，資料分析複雜性、標準化問題和有關遺傳隱私的道德考慮等挑戰可能會阻礙市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球宏基因組市場的每個細分市場進行了包容性評估。宏基因組學產業的成長和趨勢為這項研究提供了一種整體方法。

市場區隔

宏基因組市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

依產品類型

儀器
試劑盒和試劑
軟體與服務

依技術

16S定序
全基因組定序
鳥槍式定序
其他

按申請

生態與環境
臨床診斷
藥物發現
生物技術
食品和飲料
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲宏基因組學市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。宏基因體學市場的主要參與者包括Thermo Fisher Scientific, Inc.、Qiagen、Illumina, Inc.、Promega Corporation、Novogene Co., Ltd.、Takara Bio Inc.、Oxford Nanopore Technologies plc、Arc Bio, LLC、Eurofins Scientific 、 Zymo Research、Microsynth AG、F. Hoffmann-La Roche Ltd.、PerkinElmer, Inc.、Computomics GmbH。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：宏基因組公司的競爭格局

宏基因組市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Thermo Fisher Scientific Inc.

公司簡介
公司收入
產品
最近的發展

Qiagen

公司簡介
公司收入
產品
最近的發展

Illumina Inc.

公司簡介
公司收入
產品
最近的發展

Promega Corporation

公司簡介
公司收入
產品
最近的發展

Novogene Co. Ltd.

公司簡介
公司收入
產品
最近的發展

Takara Bio Inc.

公司簡介
公司收入
產品
最近的發展

Oxford Nanopore Technologies plc

公司簡介
公司收入
產品
最近的發展

Arc Bio LLC

公司簡介
公司收入
產品
最近的發展

Eurofins Scientific

公司簡介
公司收入
產品
最近的發展

Zymo Research

公司簡介
公司收入
產品
最近的發展

Microsynth AG

公司簡介
公司收入
產品
最近的發展

F. Hoffmann-La Roche Ltd.

公司簡介
公司收入
產品
最近的發展

PerkinElmer Inc.

公司簡介
公司收入
產品
最近的發展

Computomics GmbH

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112114033

The global demand for Metagenomics Market is presumed to reach the market size of nearly USD 7.68 Billion by 2032 from USD 2.38 Billion in 2023 with a CAGR of 13.91% under the study period 2024 - 2032.

Metagenomics is a scientific approach to studying genetic material recovered from environmental samples, such as water, soil, or the human body, without isolating and culturing individual organisms. It provides insights into microbial communities' genetic composition, diversity, and functional potential within these environments and allows researchers to understand microorganisms' roles in various ecosystems, including their impact on human health, agriculture, and environmental processes.

MARKET DYNAMICS

Advancements in sequencing technologies and bioinformatics tools drive the Metagenomics market. Metagenomic research has enabled scientists to analyze complex microbial communities with unprecedented depth and accuracy. Additionally, the growing awareness of the human microbiome's role in health and disease has fueled demand for metagenomic solutions in personalized medicine, probiotics, and microbiome therapeutics. Moreover, government initiatives and funding support for research in microbiome science have accelerated market growth by fostering innovation and collaboration among academic, industrial, and governmental institutions. Furthermore, the expanding use of metagenomics in food safety, industrial bioprocessing, and environmental remediation underscores its versatility and market potential. However, challenges such as data analysis complexity, standardization issues, and ethical considerations regarding genetic privacy may hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of metagenomics. The growth and trends of metagenomics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the metagenomics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Instruments
Kits & Reagents
Software & Services

By Technology

16S Sequencing
Whole Genome Sequencing
Shotgun Sequencing
Others

By Application

Ecology & Environment
Clinical Diagnostics
Drug Discovery
Biotechnology
Food & Beverages
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Metagenomics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Metagenomics market include Thermo Fisher Scientific, Inc., Qiagen, Illumina, Inc., Promega Corporation, Novogene Co., Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Arc Bio, LLC, Eurofins Scientific, Zymo Research, Microsynth AG, F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., Computomics GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . METAGENOMICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL METAGENOMICS MARKET ANALYSIS BY PRODUCT TYPE

5.1 Overview by Product Type
5.2 Historical and Forecast Data
5.3 Analysis by Product Type
5.4 Instruments Historic and Forecast Sales by Regions
5.5 Kits & Reagents Historic and Forecast Sales by Regions
5.6 Software & Services Historic and Forecast Sales by Regions

6 . GLOBAL METAGENOMICS MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 16S Sequencing Historic and Forecast Sales by Regions
6.5 Whole Genome Sequencing Historic and Forecast Sales by Regions
6.6 Shotgun Sequencing Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL METAGENOMICS MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Ecology & Environment Historic and Forecast Sales by Regions
7.5 Clinical Diagnostics Historic and Forecast Sales by Regions
7.6 Drug Discovery Historic and Forecast Sales by Regions
7.7 Biotechnology Historic and Forecast Sales by Regions
7.8 Food & Beverages Historic and Forecast Sales by Regions
7.9 Others Historic and Forecast Sales by Regions

8 . GLOBAL METAGENOMICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE METAGENOMICS COMPANIES

9.1. Metagenomics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF METAGENOMICS INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Thermo Fisher Scientific Inc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Qiagen
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Illumina Inc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Promega Corporation
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Novogene Co. Ltd.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Takara Bio Inc.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Oxford Nanopore Technologies plc
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Arc Bio LLC
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Eurofins Scientific
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Zymo Research
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. Microsynth AG
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments
10.14. F. Hoffmann-La Roche Ltd.
- 10.14.1. Company Overview
- 10.14.2. Company Revenue
- 10.14.3. Products
- 10.14.4. Recent Developments
10.15. PerkinElmer Inc.
- 10.15.1. Company Overview
- 10.15.2. Company Revenue
- 10.15.3. Products
- 10.15.4. Recent Developments
10.16. Computomics GmbH
- 10.16.1. Company Overview
- 10.16.2. Company Revenue
- 10.16.3. Products
- 10.16.4. Recent Developments